Clinical trial
Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
NCT01910012 is registered in ClinicalTrials.gov with Polaris Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
- Lead sponsor
- Polaris Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 6, 2015
- Completion date
- May 5, 2017
- Enrollment
- 43 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia